Everything You Need to Know About the Leading Donor-Derived Starting Material Focused Conference
The 3rd Donor Selection & Cell Source Summit 2025 is the world’s leading conference dedicated to focusing on the impact that donor-derived starting material has on allogeneic product development. This summit unites leaders from biopharma, blood banks, and apheresis suppliers to collaboratively tackle challenges in donor screening, recruitment, and retention. With over 600 clinical trials underway, ensuring a consistent and reliable supply of high-quality starting material is paramount.
Who Should Attend This Summit?
- Allogeneic R&D
- Manufacturing and CMC
- Clinical development and medical affairs
- Quality assurance and control
- Biotech leadership and investment
- Academic research
Whether you're developing your first allogeneic product or looking to advance your existing pipelines, this event offers actionable insights for every stage your development
What Topics Will be Covered at the Summit?
The agenda is designed to deliver practical, forward-looking content, here are some highlights:
- Next-gen computational tools for donor screening to improve efficiency and predict product outcomes with greater accuracy
- Defining the “super donor” and understanding factors driving starting material quality so your criteria is based on data, not stereotypes
- Managing donor variability across PBMCs, iPSCs, and cord blood, with case studies from leading allogeneic developers
- Funding and investment strategies with seasoned investors who’ve successfully guided companies through the current market landscape
Has my Company attended this Summit Before?
Very likely! Below you can find the list of companies that previously benefited by attending this summit!
- Allogene Therapeutics
- AlloVir
- Artiva Biotherapeutics
- AstraZeneca
- Atara Biotherapeutics
- BioBridge Global
- Biopharma Excellence
- Brigham and Women's Hospital
- Bristol Myers Squibb
- Cargo Therapeutics
- Caribou Biosciences
- Carve Bio
- Children's National Medical Center
- CytoImmune Therapeutics
- Cytovia Therapeutics
- Deverra Therapeutics
- Editas Medicine
- Genentech
- GentiBio
- HebeCell
- ICCBBA
- Immatics
- ImmuneBridge
- Imugene
- Legend Biotech
- Nkarta
- Onk Therapeutics
- OrganaBio
- Poseida Therapeutics
- Sana Biotechnology
- Sanguine Biosciences
- Senti Biosciences
- Shoreline Biosciences
- TCBiopharm
- Tevogen Bio
- Tiba Biotech
- Tr1x Therapeutics
- University of Alberta
- Versiti
I want to Attend, but how do I Convince My Boss?
We understand you may be interested in attending the summit but might not be sure where to start with making your case with your seniors.
This is why we build the "Make Your Case" page with the purpose of giving you the resources and reasons to convince your boss that this is the ideal summit for you and your team to attend for 2025.
Are There Any Discounts Available?
Yes!
We offer up to 20% off for teams registering multiple attendees. This is perfect for cross-functional groups looking to gain insights across R&D, CMC, clinical, and regulatory domains.
You can find further details of the discounts on the event brochure or by reaching out to our audience team.